Vol 26, No 6 (2019)
Original articles — Clinical cardiology
Published online: 2019-01-30

open access

Page views 1931
Article views/downloads 776
Get Citation

Connect on Social Media

Connect on Social Media

Postoperative high-sensitivity troponin T as a predictor of sudden cardiac arrest in patients undergoing cardiac surgery

Piotr Duchnowski1, Tomasz Hryniewiecki1, Mariusz Kuśmierczyk1, Piotr Szymański1
Pubmed: 30701514
Cardiol J 2019;26(6):777-781.

Abstract

Background: The usefulness of high-sensitivity troponin T (hs-TnT) as a predictor of sudden cardiac
arrest (SCA) in patients undergoing valve surgery is currently unknown.
Methods: A prospective study was conducted on a group of 815 consecutive patients with significant
valvular heart disease that underwent elective valve surgery. The primary end-point was postoperative SCA.
Results: The postoperative SCA occurred in 26 patients. At multivariate analysis of hs-TnT measured
immediately after surgery (hs-TnT I) and age remained independent predictors of the primary end-point.
Conclusions: Elevated postoperative hs-TnT was associated with a higher risk of postoperative SCA.

Article available in PDF format

View PDF Download PDF file

References

  1. Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. ESC Scientific Document Group . 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015; 36(41): 2793–2867.
  2. Eckart RE, Shry EA, Burke AP, et al. Sudden death in young adults: an autopsy-based series of a population undergoing active surveillance. J Am Coll Cardiol. 2011; 58(12): 1254–1261.
  3. Van Camp SP, Bloor CM, Mueller FO, et al. Nontraumatic sports death in high school and college athletes. Med Sci Sports Exerc. 1995; 27(5): 641–647.
  4. Drory Y, Turetz Y, Hiss Y, et al. Sudden unexpected death in persons less than 40 years of age. Am J Cardiol. 1991; 68(13): 1388–1392.
  5. Basso C, Carturan E, Pilichou K, et al. Sudden cardiac death with normal heart: molecular autopsy. Cardiovasc Pathol. 2010; 19(6): 321–325.
  6. Arking DE, Junttila MJ, Goyette P, et al. Identification of a sudden cardiac death susceptibility locus at 2q24.2 through genome-wide association in European ancestry individuals. PLoS Genet. 2011; 7(6): e1002158.
  7. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002; 346(12): 877–883.
  8. Gualandro DM, Puelacher C, Mueller C. High-sensitivity cardiac troponin in acute conditions. Curr Opin Crit Care. 2014; 20(5): 472–477.
  9. Parissis JT, Papadakis J, Kadoglou NPE, et al. Prognostic value of high sensitivity troponin T in patients with acutely decompensated heart failure and non-detectable conventional troponin T levels. Int J Cardiol. 2013; 168(4): 3609–3612.
  10. Guo R, Li Y, Wen J, et al. Elevated plasma level of pentraxin-3 predicts in-hospital and 30-day clinical outcomes in patients with non-ST-segment elevation myocardial infarction who have undergone percutaneous coronary intervention. Cardiology. 2014; 129(3): 178–188.
  11. Duchnowski P, Hryniewiecki T, Zatorska K, et al. High‑sensitivity troponin T as a prognostic marker in patients undergoing aortic valve replacement. Pol Arch Intern Med. 2017; 127(9): 628–630.
  12. Petäjä L, Røsjø H, Mildh L, et al. Predictive value of high-sensitivity troponin T in addition to EuroSCORE II in cardiac surgery. Interact Cardiovasc Thorac Surg. 2016; 23(1): 133–141.
  13. Duchnowski P, Hryniewiecki T, Kuśmierczyk M, et al. The usefulness of selected biomarkers in aortic regurgitation. Cardiol J. 2018 [Epub ahead of print].
  14. Reichlin T, Schindler C, Drexler B, et al. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch Intern Med. 2012; 172(16): 1211–1218.
  15. European patent 394816 and US patent 6376206 by Roche Diagnostic GmbH. Specific antibodies to Troponin T, their production and use in a reagent for the determination of myocardial necrosis.
  16. Apple FS, Ler R, Murakami MM. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem. 2012; 58(11): 1574–1581.
  17. Lepojärvi ES, Huikuri HV, Piira OP, et al. Biomarkers as predictors of sudden cardiac death in coronary artery disease patients with preserved left ventricular function (ARTEMIS study). PLoS One. 2018; 13(9): e0203363.
  18. Beausire T, Faouzi M, Palmiere C, et al. High-sensitive cardiac troponin hs-TnT levels in sudden deaths related to atherosclerotic coronary artery disease. Forensic Sci Int. 2018; 289: 238–243.
  19. Sharma A, Hijazi Z, Andersson U, et al. Use of biomarkers to predict specific causes of death in patients with atrial fibrillation. Insights from the ARISTOTLE Trial. Circulation. 2018; 138(16): 1666–1676.
  20. Nakamura H, Niwano S, Fukaya H, et al. Cardiac troponin T as a predictor of cardiac death in patients with left ventricular dysfunction. J Arrhythm. 2017; 33(5): 463–468.
  21. Carvajal-Zarrabal O, Hayward-Jones PM, Nolasco-Hipolito C, et al. Use of cardiac injury markers in the postmortem diagnosis of sudden cardiac death. J Forensic Sci. 2017; 62(5): 1332–1335.
  22. Rahimi R, Dahili ND, Anuar Zainun K, et al. Post mortem troponin T analysis in sudden death: Is it useful? Malays J Pathol. 2018; 40(2): 143–148.
  23. Lindman BR, Breyley JG, Schilling JD, et al. Prognostic utility of novel biomarkers of cardiovascular stress in patients with aortic stenosis undergoing valve replacement. Heart. 2015; 101(17): 1382–1388.
  24. Hein S, Arnon E, Kostin S, et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation. 2003; 107(7): 984–991.
  25. Weidemann F, Herrmann S, Störk S, et al. Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation. 2009; 120(7): 577–584.
  26. Abramov D, Abu-Tailakh M, Frieger M, et al. Plasma troponin levels after cardiac surgery vs after myocardial infarction. Asian Cardiovasc Thorac Ann. 2006; 14(6): 530–535.
  27. Opfermann UT, Peivandi AA, Dahm M, et al. Postoperative patterns and kinetics of cTnI, cTnT, CK-MB-activity and CK-activity after elective aortic valve replacement. Swiss Med Wkly. 2001; 131(37-38): 550–555.